Chiara Molinelli
Genoa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Dose-dense adjuvant chemotherapy in HER2-low breast cancer: An exploratory analysis of the GIM2 trial.
Journal: Breast (Edinburgh, Scotland)
Published: May 12, 2026
Long-term immune response to mRNA anti-SARS-CoV-2 vaccination in patients with cancer.
Journal: Frontiers in immunology
Published: February 23, 2026
Comparison of suboptimal versus adequate ovarian function suppression in premenopausal women with early breast cancer treated with adjuvant endocrine therapy: An exploratory analysis of two prospective studies.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 01, 2025
Long-term outcomes and treatment response in early-stage invasive lobular carcinoma: insights from a nationwide population-based study.
Journal: ESMO open
Published: October 30, 2025
The role of body mass index at diagnosis in patients with inflammatory breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: June 18, 2025
Physicians' knowledge, practice, and attitudes on fertility and pregnancy-related issues in young women with advanced breast cancer: results of the ABC6 and ABC7 survey.
Journal: Breast (Edinburgh, Scotland)
Published: March 27, 2025
Real-World 5-Year Outcomes of Patients Treated With the Adjuvant Paclitaxel Trastuzumab (APT) Regimen for Stage I HER2-Positive Early Breast Cancer: A Retrospective International Study.
Journal: Clinical breast cancer
Published: February 27, 2025
Adverse events and impact on quality of life of antibody-drug conjugates in the treatment of metastatic breast cancer: A systematic review and meta-analysis.
Journal: European journal of clinical investigation
Published: December 05, 2024
Corrigendum to "Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: Biomarkers and beyond" [Crit. Rev. Oncol./Hematol. 200C (2024) 104404].
Journal: Critical reviews in oncology/hematology
Published: November 05, 2024
The journey of patients affected by metastatic hormone receptor-positive/HER2-negative breast cancer from CDK 4/6 inhibitors to second-line treatment: A real-world analysis of 701 patients enrolled in the GIM14/BIOMETA study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 03, 2024
Controversies on chemotherapy for early HR+/HER2- breast cancer: the role of anthracyclines and dose intensification.
Journal: Current opinion in oncology
Published: July 16, 2024
Last Updated: 09/26/2026